CINFINI Trademark

Trademark Overview

On Wednesday, May 5, 2021, a trademark application was filed for CINFINI with the United States Patent and Trademark Office. The USPTO has given the CINFINI trademark a serial number of 79314236. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Sunday, February 25, 2024. This trademark is owned by NOVARTIS AG. The CINFINI trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical and biological preparations for the prevention and treatment of diseases and disorders of the nervous system, the immune system, the cardiovascular system, the metabolic system, the endocrine system, the respiratory system, the musculo-skeletal system and the genitourinary system and for the treatment of inflammatory diseases and disorders; pharmaceutical and biological preparations for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for treatment of gastroenterological diseases and disorders; pharmaceutical and biological preparations for the prevention and treatment of ocular disorders and diseases, for the treatment of diseases and disorders caused by bacteria, autoimmune diseases and disorders, kidney diseases and disorders, diabetes; pharmaceutical and biological preparations, namely, anti-fungal, anti-infective, antiviral and antibiotic preparations
cinfini

General Information

Serial Number79314236
Word MarkCINFINI
Filing DateWednesday, May 5, 2021
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateSunday, February 25, 2024
Registration Number6891319
Registration DateTuesday, November 8, 2022
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 23, 2022

Trademark Statements

Goods and ServicesPharmaceutical and biological preparations for the prevention and treatment of diseases and disorders of the nervous system, the immune system, the cardiovascular system, the metabolic system, the endocrine system, the respiratory system, the musculo-skeletal system and the genitourinary system and for the treatment of inflammatory diseases and disorders; pharmaceutical and biological preparations for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for treatment of gastroenterological diseases and disorders; pharmaceutical and biological preparations for the prevention and treatment of ocular disorders and diseases, for the treatment of diseases and disorders caused by bacteria, autoimmune diseases and disorders, kidney diseases and disorders, diabetes; pharmaceutical and biological preparations, namely, anti-fungal, anti-infective, antiviral and antibiotic preparations

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status CodeH - NOT AVAILABLE
Class Status DateSunday, February 25, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNOVARTIS AG
Party Type30 - Original Registrant
Legal Entity Type25 - NOT AVAILABLE
AddressCH
Party NameNOVARTIS AG
Party Type20 - Owner at Publication
Legal Entity Type25 - NOT AVAILABLE
AddressCH
Party NameNOVARTIS AG
Party Type10 - Original Applicant
Legal Entity Type25 - NOT AVAILABLE
AddressCH

Trademark Events

Event DateEvent Description
Wednesday, July 7, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, June 25, 2021SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
Tuesday, July 6, 2021LIMITATION FROM ORIGINAL APPLICATION ENTERED
Friday, July 9, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, July 9, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, July 9, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, July 9, 2021TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Friday, July 9, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, July 9, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, July 13, 2021APPLICATION FILING RECEIPT MAILED
Thursday, September 9, 2021ASSIGNED TO EXAMINER
Thursday, September 16, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 6, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 26, 2021PUBLISHED FOR OPPOSITION
Tuesday, October 26, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 23, 2021CORRECTION TRANSACTION RECEIVED FROM IB
Thursday, February 10, 2022GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Tuesday, January 11, 2022REGISTERED-PRINCIPAL REGISTER
Tuesday, March 8, 2022REQUEST TO CANCEL INADVERTENTLY ISSUED REGISTRATION RECEIVED
Wednesday, March 9, 2022ASSIGNED TO PETITION STAFF
Friday, March 11, 2022REG. CANCELLED - RESTORED TO PENDENCY
Tuesday, July 19, 2022CORRECTION FROM IB ENTERED - ATTORNEY REVIEW REQUIRED
Tuesday, May 3, 2022FINAL DISPOSITION REVIEWED - NO ACTION REQUIRED BY OFFICE
Wednesday, August 3, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, August 3, 2022NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, August 3, 2022NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Tuesday, August 23, 2022PUBLISHED FOR OPPOSITION
Tuesday, August 23, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sunday, September 4, 2022NOTIFICATION PROCESSED BY IB
Tuesday, November 8, 2022REGISTERED-PRINCIPAL REGISTER
Tuesday, December 13, 2022FINAL DISPOSITION PROCESSED
Tuesday, November 8, 2022NOTICE OF REGISTRATION CONFIRMATION EMAILED
Thursday, December 8, 2022GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Tuesday, December 13, 2022FINAL DISPOSITION NOTICE SENT TO IB
Tuesday, October 8, 2024DEATH OF INTERNATIONAL REGISTRATION
Tuesday, October 8, 2024NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Sunday, January 8, 2023NOTIFICATION PROCESSED BY IB

Related Keywords

cinfini system disorders diseases treatment preparations pharmaceutical biological prevention anti bacteria